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Human adipose tissue is a great source of autologous mesenchymal stem cells (hASCs), which are recognized for their vast
therapeutic applications. Their ability to self-renew and differentiate into several lineages makes them a promising tool for cell-
based therapies in different types of degenerative diseases.Thus it is crucial to evaluate age-related changes in hASCs, as the elderly
are a group that will benefit most from their considerable potential. In this study we investigated the effect of donor age on growth
kinetics, cellular senescence marker levels, and osteogenic and adipogenic potential of hASCs. It also has been known that, during
life, organisms accumulate oxidative damage that negatively affects cell metabolism. Taking this into consideration, we evaluated
the levels of nitric oxide, reactive oxygen species, and superoxide dismutase activity. We observed that ROS and NO increase with
aging, while SOD activity is significantly reduced. Moreover cells obtained from older patients displayed senescence associated
features, for example,𝛽-galactosidase activity, enlargedmorphology, and p53 protein upregulation. All of those characteristics seem
to contribute to decreased proliferation potential of those cells. Our results suggest that due to aging some cellular modification
may be required before applying aged cells efficiently in therapies such as tissue engineering and regenerative medicine.
1. Introduction
One of the currently fastest developing fields of medical
science is regenerative medicine. This results from the need
for advanced treatment options for many diseases, which
are becoming more frequent due to the aging of society.
The main target populations that may most benefit from
advances in regenerative medicine are elderly patients. In
recent years, many basic researchers as well as clinical groups
showed the positive effect of mesenchymal stem cells (MSCs)
as therapeutic agents, both in vivo and in vitro [1, 2]. MSCs,
in general, are characterized as a source of cells that possess a
unique proliferative potential, the ability to self-renew, and
can also differentiate in vitro into multiple lineages [3–5].
Besides proliferative and differentiation potential, MSCs are
well known for their immunomodulatory and immunosup-
pressive properties, which make them an even more promis-
ing tool in regenerative medicine [6]. In a wide range of ani-
mal model studies [7], it has been demonstrated that MSCs
can be successfully applied in regeneration ofmusculoskeletal
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tissues [8], cardiac tissues [9], andneurological disorders [10].
One of the potential explanations of the regenerative ability
of MSCs is paracrine action through secretion of membrane
derived vesicles (MVs) which contain a wide range of growth
factors, aswell as antiapoptotic and anti-inflammatory factors
[11]. The most often investigated and described in literature
MSC populations are those isolated from bonemarrow (bone
marrow derived mesenchymal stem cells (BMSC)) and those
of adipose origin (human adipose derivedmesenchymal stem
cells (hASC)).However, BMSCapplication is limited, because
of the rather complicated acquisition process, requirement
of using extensive anesthesia, and finally low cell yield [12].
Compared with BMSCs, hASCs have distinct advantages in
cell preparation due to ease and safety of adipose tissue
obtaining. Human ASCs, like BMSCs, are characterized by
similar phenotype, stability over long term culture, and
extended efficiency in vitro [13]. Moreover, in our previous
study we have shown that hASCs, in comparison to BMSCs,
have greater potential for osteogenic differentiationwhen cul-
tured onto metallic biomaterials [14]. Thereby, consideration
of hASCs’ application in clinical practice seems to be more
real in the shorter perspective. Because of the growing interest
in stem cell-based therapy and tissue engineering there are
some points which should be addressed before their clinical
application, especially in the context of elderly donors. It was
demonstrated that donor age negatively correlates with the
number and proliferative potential of BMSCs, at the same
time positively correlating with the level of cell apoptosis and
senescence [15].
Recently, a growing number of factors are being analyzed
in order to investigate their role in MSCs aging and their
potential input in MSCs proliferative and differentiative
status [16]. Oxidative stress, as an imbalance between free
radicals and antioxidants, has been reported to influence
MSCs multipotent character on the level of particular gene
expression, proliferation, and differentiation. Oxidative stress
factors including reactive oxygen species (ROS) and nitric
oxygen (NO) are implicated in cellular proliferation and
differentiation capacity [17]. They are also involved in ini-
tiating apoptosis, which is characterized by upregulation of
the p53 gene (tumor suppressor), changes in the expression
of pro- and antiapoptotic Bcl-2 family members, cytochrome
C relocation, activation of caspases, chromatin condensation,
and DNA fragmentation [18]. On the other hand, the activity
of free radicals scavengers, like superoxide dismutase (SOD),
that balance the effects of free radicals might have a crucial
role in evaluation of MSCs both proliferative and differentia-
tive status in the context of donor age.
Recently, there is a growing interest in the application of
hASCs in clinical practice and tissue engineering. Thus the
evaluation of their cytophysiological features in the context
of donor age seems to be necessary. Bearing in mind the
fact that the regenerative potential of MSCs is linked to
their proliferative, differentiative, and paracrine activity, in
this study we evaluated hASCs morphology, growth kinetics,
and osteogenic versus adipogenic differentiation potential of
cells obtained from donors of different age. We performed
our study in regard to gene expression profile, correlation of
ROS/NO versus SOD activity, and senescence level.
2. Materials and Methods
2.1. Cell Collection and Isolation. The protocol was approved
by the Local BioethicsCommittee ofWroclawMedical School
(registry number KB-177/2014). All donors had given their
written informed consent prior to the procedure. The study
has been performed in accordance with the ethical standards
laid down in the 1964 Declaration of Helsinki and its later
amendments.
Human subcutaneous adipose tissue was collected from
both male and female subjects, age range 23–77 years (54.3 ±
21.9) during total hip arthroplasty. Patients were divided into
4 age groups: >20 (age range 20–29, 𝑛 = 7, mean age 24 ± 1.4
years), >50 (age range 50–60, 𝑛 = 7, mean age 57.5±0.7), >60
(age range 60–69, 𝑛 = 7, age 67), and >70 (age range 70–79,
𝑛 = 7, mean age 75 ± 2.8).
All adipose tissue samples were processed under the same
conditions. After surgical harvesting adipose tissue samples
were placed in Hank’s Balanced Salt Solution (HBSS, Sigma
Aldrich). Adipose derived stem cells’ isolationwas performed
according to a previously described protocol by Grzesiak
et al. [19] and Marycz et al. [20], under sterile conditions.
Briefly, the tissue was washed extensively with HBSS sup-
plemented with 1% antibiotic-antimycotic solution (peni-
cillin/streptomycin/amphotericin B solution, Sigma Aldrich)
and then cut into small pieces using surgical scissors. The
extracellular matrix was digested with 1mg/mL collagenase
type I (Sigma Aldrich) and incubated for 40 minutes at 37∘C.
Then the suspension was centrifuged at 1200 g for 10 minutes.
After removing the supernatant, the pellet was resuspended
in the culture medium and transferred to a culture flask.
Primary culture of hASCs’ was designated as “passage 0.” To
prepare cells for experiment, they were passaged three times.
2.2. Immunophenotyping. Human ASCs were recognized by
immunophenotyping using fluorochrome conjugated mon-
oclonal antibodies specific for CD29, CD34, CD45, CD90,
CD73b, CD44, and CD105 (all antibodies purchased from
BD Pharmingen). Isotype-matched antibodies were used as
controls. Due to immunophenotyping hASCs from passage 1
were detached using TrypLEExpress solution (Life Technolo-
gies), washed with phosphate buffered saline (PBS, Sigma
Aldrich) containing 2% FBS, and resuspended at total of
5 ∗ 105 cells/mL. Cell suspension was incubated at 4∘C for
20min with the specific antibodies preconjugated with allo-
phycocyanin (APC), peridinin chlorophyll protein complex
(PerCP), fluorescein isothiocyanate (FITC), or phycoerythrin
(PE). At least ten thousand stained cells were acquired and
analyzed by Becton Dickinson FACS Calibur flow cytometer.
The samples were analyzed using FlowJo software (TreeStar).
2.3. Cell Culture. During the experiment, cells were cultured
under aseptic and unchanging conditions in an incubator
(37∘C, 5% CO2, and 95% humidity). Primary cultures were
plated on T-25 flasks in culture media containing Dulbecco’s
Modified Eagle’s Medium (DMEM, Sigma Aldrich) with
nutrient F-12Ham, 10% of Fetal Bovine Serum (FBS, Sigma
Aldrich), and 1% solution of P/S/A. The media were changed
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every second day. Passage was performed when cells reached
about 80% confluence. Human ACSs culture passaging was
performed using TrypLE Express solution according to man-
ufacturer protocol. Passaged cultures were denoted as passage
1.
2.4. Colony Forming Unit-Fibroblastic Assay (CFU-F), Cell
Proliferation Assay, and hASC Morphology Evaluation. To
evaluate the ability to form colonies, the CFU-F assay was
performed as described previously with modifications [21].
Briefly, cells were plated on six-well culture plates at the
appropriate density (1 ∗ 103 cells/well) in culture media
(DMEM, 10% FBS, 1% P/S/A). The medium was changed
every two days and cultures weremaintained for 7 days. After
fixation in 4% ice-cold paraformaldehyde, cells were stained
with pararosaniline (Sigma Aldrich) and colonies of more
than 50 cells were scored. The efficiency of colony forming
(CFE) ability was calculated using the formula mentioned
below, as presented elsewhere [22]
CFE [%] = (number of colonies
initial cell number
) ⋅ 100%. (1)
Cell proliferation rate was evaluated using 10% resazurin-
based dye-TOX-8 (Sigma Aldrich) following manufacturer’s
protocols. To perform the assay, media were collected and
replaced with the culture medium containing 10% resazurin
dye solution. Then cultures were incubated with dye in a
CO
2
incubator, 37∘C for 2 hours. Next, the supernatants
were collected and transferred to a 96-well plate to perform
the spectrophotometric assay (BMG Labtech, Germany).
The absorbance was measured at a wavelength of 600 nm
for resazurin and 690 nm reference wavelength. Each test
included a blank (dye containing medium without cells) for
control.The test was performed at the 2nd, 5th, 7th, 12th, 14th,
and 16th day of the experiment. Cell number was obtained
from test data. Population doubling timewas calculated using
online software [23].
Cells’ morphology (induced and noninduced) was eval-
uated using an epifluorescent microscope (Zeiss, Axio
Observer A.1) and a scanning electron microscope (SEM,
Zeiss Evo LS 15). Morphology analysis was performed on
the 7th (noninduced cells), 14th day (cells from adipogenic
differentiation), and 16th day (cells from osteogenic dif-
ferentiation). Prior to fluorescent microscopy observations
samples were first (a) rinsed three times with HBSS; (b)
fixed with 4% paraformaldehyde for 45min; (c) washed
again (as described above); (d) permeabilized for 15min
with 0.1% Triton X-100 at room temperature and washed
again. Actin filaments were stained using atto-488-labeled
phalloidin (Sigma Aldrich) at dilution 1 : 800 with HBSS
for 40 minutes in the dark at room temperature and cells’
nuclei were counterstained with diamidino-2-phenylindole
(DAPI; 1 : 1000, Sigma Aldrich) for 5 minutes. Mitochondria
were stained intravitally using Mito Red fluorescence dye
(Sigma Aldrich) following manufacturer’s protocol. Tubulin
was labeled with red fluorescent protein in live cells with
CellLight Tubulin-RFP, BacMam 2.0 (Life Technologies), and
the Golgi apparatus was stained green with CellLight Golgi-
GFP, BacMam 2.0 (Life Technologies). Cells’ nuclei were
counterstained withDAPI. All procedures were performed in
accordancewithmanufacturer’s protocols. Images were taken
using Canon PowerShot Camera.
2.5. Oxidative Stress Factors and Senescence Analysis in hASCs
Culture. To evaluate stress levels, cells were cultured in
normal growth media without phenol red for two days.
Nitric oxide concentration was assessed using commercially
available Griess reagent kit (Life Technologies). Superoxide
dismutase (SOD) activity was measured using a SOD Assay
kit (Sigma Aldrich). Reactive oxygen species (ROS) were
estimated by incubating cells with anH2DCF-DA (Life Tech-
nologies) solution. All procedures were performed according
to manufacturer’s protocols.
To identify the presence of senescence associated 𝛽-
galactosidase (𝛽-gal), cells were stained using a com-
mercial kit (Senescence Cells Histochemical Staining Kit,
Sigma Aldrich) according to manufacturer’s protocol. Super-
natant was then collected and followed by measurement of
absorbance. Cells were then observed under an inverted
microscope (Zeiss, AxioObserverA.1) and percentage of cells
expressing 𝛽-gal (stained blue) in regard to 𝛽-gal negative
cells was calculated.
Amount of viable and dead cells was evaluated with Cell-
stain Double Staining Kit (Sigma Aldrich). Viable cells were
stained with Calcein-AM and emitted green fluorescence,
whereas dead cells’ nuclei were stained orange with Pro-
pidium Iodide. Cells were then observed using fluorescence
microscopy (Zeiss, Axio Observer A.1). The percentage of
dead cells was calculated. All procedures were performed in
accordance with manufacturer’s instructions.
Staining for caspase-3 was performed using anti-caspase-
3 antibodies (anti-caspase-3-active antibody produced in
rabbit, Sigma Aldrich, category number C8487).
2.6. Multipotency Assay: Oil Red O, Alizarin Red Stain-
ing, SEM, and SEM-EDX Analysis. To identify the multi-
lineage differentiation potential of hASCs, a multipotency
test was performed using commercially available differen-
tiation media (STEMPRO Osteogenesis Differentiation Kit
and STEMPRO Adipogenesis Differentiation Kit, both Life
Technologies). The cells were seeded onto 24-well dishes
at a concentration 2 ∗ 104 cells per well. Stimulation of
adipogenesis lasted 14 days, whereas osteogenesis lasted 16
days. All procedures were performed according to man-
ufacturer’s instructions. Media were changed every three
days. Cultures expanded in standard growth medium were
used as a control to allow for establishing differentiation
effectiveness. Multilineage differentiation was confirmed at 2
weeks after induction by cells staining. Multipotency test was
performed on ASCs isolated from patients between 25 and 77
age ranges.
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To identify intracellular lipid vacuoles and confirm adi-
pogenesis, the Oil Red O (Sigma Aldrich) staining was
performed. Media were removed and the cells were fixed
in 4% paraformaldehyde at room temperature for 45min,
followed by incubation with 60% isopropanol for 5min.
Slides were then incubated with Oil-Red O for 15 minutes.
The cells were also counterstained with haematoxylin for
1min. Excessive dye was washed away with PBS. The Oil
Red O-stained areas, as a marker of lipid accumulation, were
analyzed using Image J software (NIH). In each group, the
mean for five independent sections was used for the analysis.
To visualize extracellular matrix mineralization, cells
were fixed with 4% paraformaldehyde at room temperature
for 10min. After washing with distilled water, 2% Alizarin
Red solution was added to wells. After 10min the dye
was removed and cells were washed with distilled water 3
times. Cells were observed under an inverted microscope
(AxioObserverA1, Zeiss) and pictures were taken using
Canon PowerShot digital camera.
Detailed cell morphologywas evaluated using SEM (EVO
LS15, Zeiss). In order to perform observations cells were
rinsed with distilled water and dehydrated in graded ethanol
series (concentrations from 50% to 100%). Dehydrated sam-
ples were then sputtered with gold (ScanCoat 6, Oxford),
placed in a microscope chamber, and observed using the SE1
detector, at 10 kV of filament’s tension. Additionally calcium
and phosphorus concentration was analyzed by SEM with
energy dispersive X-ray analysis (SEM/EDX). The quantax
detector (Brüker) with 10 kV of filament tension was used to
perform a line scan analysis of randomly selected cells. The
obtained values were presented as weight percentage (wt%).
Moreover, using SEM/EDX technique, we estimated number
and size of bone nodules in each age group.
2.7. Quantitative Osteopontin, Osteocalcin, Collagen Type
I, Leptin, Adiponectin, and Alkaline Phosphatase Activity
Assay. To examine extracellular protein levels, supernatants
of cultures were collected and analyzed by enzyme-linked
immunosorbent assay (ELISA). The presence of osteopontin
(OPN) and collagen type 1 (Col-1) was determined on the
16th day using Human OPN Quantikine ELISA Kit (R&D
Systems, Abingdon, UK) and Human Pro-Collagen I alpha
1 DuoSet (R&D Systems, Abingdon, UK), respectively. To
evaluate the amount of adiponectin and leptin supernatants
were collected on the 14th day and an ELISA assay was
performed (Wuhan EIAab Science Co., China). Analysis was
performed in accordance with manufacturers’ protocols, and
protein amount was expressed as ng/mL of supernatant.
To estimate extracellular alkaline phosphatase (ALP)
activity, supernatants were collected at 2nd, 7th, 11th, 14th,
and 16th day. Assay was performed using an Alkaline Phos-
phatase Colorimetric Assay Kit (Abcam, Cambridge, UK)
according tomanufacturer’s protocol. Briefly, in the assay, the
p-nitrophenyl phosphate (pNPP) was used as a phosphatase
substrate. The substrate was hydrolyzed into p-nitrophenol
by ALP. The product was then measured spectroscopically at
405 nm wavelength (BMG Labtech, Germany). The amount
of pNP was obtained by sample readings applied to a stan-
dard curve. ALP activity was calculated using the following
formula: ALP activity (U/mL) = 𝐴/𝑉/𝑇 (where 𝐴 is pNP
amount; 𝑉 is volume of sample added to well (mL); 𝑇 is
reaction time)
2.8. Quantitative Real-Time Reverse Transcription Polymerase
Chain Reaction (qRT-PCR) for p53, Col-1, OPN, BMP-2,
ALP, OCN, and PPAR𝛾. After adipogenic and osteogenic
stimulation cells were rinsed usingHBSS followed by homog-
enization in TRI Reagent (Sigma Aldrich). Total RNA was
isolated using the phenol–chloroform method as previously
described by Chomczynski and Sacchi [24].
DNA-free RNA was prepared using DNase I RNase-free
kit (Thermo Scientific). Five-hundred ng of total RNA was
used for each reaction. Transcription of gDNA-free total RNA
was reverse transcribed to cDNA using oligo(dT)18 primers
and Moloney Murine Leukemia Virus Reverse Transcriptase
(M-MLV RT, Novazym). qRT-PCRs were carried out on a
CFX Connect Real-Time PCR Detection System (BioRad)
containing 2 𝜇L of cDNA in a total volume of 20𝜇L, 500 nM
primers, and the SensiFast SYBR & Fluorescein Kit (Bioline).
The sequences of the primers used for amplification of the
gene are listed in Table 1. Relative gene expression analysis
(Qn) was calculated in relation to the housekeeping gene
GAPDH.
2.9. Statistical Analysis. Group data were presented as bar
chart (mean ± SD) or box pot (Whisker’s from min to max
values) of at least 2 independent experiments (biological
replicates, 𝑛 ≥ 2) measured as duplicate or more (technical
replicates, 𝑛 ≥ 2). Statistical significance was determined
using one-way analysis of variance (ANOVA) with Tukey’s
post hoc multiple comparison test or two-way analysis of
variance (two-wayANOVA) (Prism5.04, GraphPad Software,
CA, USA). 𝑃 < 0.05 was considered statistically significant.
3. Results
3.1. Immunophenotyping and Multipotency Assay. Immuno-
phenotype characterization of hASCs using flow cytometry
revealed that cells expressed the following markers, CD44,
CD73b, CD90, and CD105, but did not express the CD34
hematopoetic lineage marker and the leukocyte common
antigen CD45 (Figure 1(a)). Percentage of cells express-
ing specific antigen was then calculated (Figure 1(b)). We
observed an age-related change in expression ofCD73marker
between young and older donors (𝑃 < 0.05). Isolated hASCs
differentiated into osteogenic, chondrogenic, and adipogenic
lineages, what was verified by means of specific staining
(Figure 1(c)).
3.2. Effect of Age on hASCs Morphology, Growth Kinetics, and
Clonogenic Potential. To evaluate growth kinetics of hASCs
isolated from four age groups, the cells were seeded at the
same initial density of 2 ∗ 103 cells/well (day 1). Cells from
younger donors (>20 years of age) displayed a significantly
higher proliferation rate in comparison to older patients,
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Table 1: Sequences of primers used in qPCR. PPAR𝛾: peroxisome proliferator-activated receptor gamma; COL-1: collagen type I; OPN:
osteopontin; BMP-2: bone morphogenetic protein 2; ALP: alkaline phosphatase; OCN: osteocalcin; p53: tumor suppressor p53; GAPDH:
glyceraldehyde 3-phosphate dehydrogenase; bp: base pair.
Gene Primer Sequence 5󸀠-3󸀠 Amplicon length (bp) Accession number
PPAR𝛾 F: AGTCCTCACAGCTGTTTGCCAAGC 125 XM 011533844.1
R: GAGCGGGTGAAGACTCATGTCTGTC
COL-1 F: GTGATGCTGGTCCTGTTGGT 123 NM 000088.3
R: CACCATCGTGAGCCTTCTCT
OPN F: AAACGCCGACCAAGGTACAG 213 U20758.1
R: ATGCCTAGGAGGCAAAAGCAA
BMP-2 F: ATGGATTCGTGGTGGAAGTG 349 KC294426.1
R: GTGGAGTTCAGATGATCAGC
ALP F: CGCGCTTGTGCCTGGA 185 XM 006710546
R: CCTGCTTTATCCCTGGAGCC
OCN F: ATGAGAGCCCTCACACTCCTC 292 NM 199173.4
R: CGTAGAAGCGCCGATAGGC
p53 F: AGATAGCGATGGTCTGGC 381 NM 001126118.1
R: TTGGGCAGTGCTCGCTTAGT
GAPDH F: CATGGCCTTCCGTGTTCCTA 286 NM 017008.4
R: CACCACCCTGTTGCTGTAGC
whereas no significant change between samples from older
donors was observed (Figure 2(a)).
The cells from younger donors (>20 years of age) reached
population doubling (PDT) the quickest (55±9.8 h) showing
a significant difference (𝑃 < 0.01) in comparison to older
patients. The longest PDT was observed in the >60 years of
age group (141.5 ± 23.8 h), showing a 2.7-fold longer PDT;
however there were no significant differences between elderly
donors (Figure 2(b)).
The greatest number of clonogenic fibroblast precursor
cells (CFU-F) was observed in younger donors (>20 years
of age). Among elderly donors a significant elevated level of
CFU-F was noticed in the >60 years group when compared
to the >50 and the >70-year-old donors (Figure 2(c)).
In the initial stage of hASCs culture, cells obtained from
young donors displayed the typical, elongated fibroblast-
like morphology. Moreover they were concentrated more
densely and closely adhere to each other. Staining after 168 h
revealedmultilayer formation and centrally positioned nuclei
(Figure 2(d)). Cells from younger donors exhibited spindle-
shaped morphology, whereas cells from >50 and >70 years of
age groups exhibited amore flat, extendedmorphology, being
amorphous in shape and no longer bipolar. Some of these
cells also displayed larger nuclei size. Culture confluence after
168 h reached approximately 80%.
To evaluate mitochondrial activity, the Mito Red staining
was applied. Fluorescence microscopy images showed a
strong fluorescent signal in younger donors when compared
to other groups (Figure 2(d)). In elderly patients, mito-
chondria were mainly located around nuclei with a strong
fluorescent signal (Figure 2(d)).
The staining for Golgi apparatus revealed comparable
fluorescent signal for all investigated groups (Figure 2(d)).
The most intensive signal for microtubules’ staining was
observed in younger donors (Figure 2(d)).
Membrane derived microvesicles (MVs) were observed
mainly on the cell border, showing the greatest distribution
in the >20 years patients. Morphological variations of shape
and amount of lamellipodia were also observed. Cells from
the >20 and >60-year-old age groups developed the longest
structures which were able to connect neighboring cells. The
smallest-scale cytonemes web was found in the >70 years of
age group.
3.3. Effect of Age on Senescence and Apoptosis. We examined
qualitative (Figure 3(c)) and quantitative, by amount of dye
absorption (Figure 3(a)) 𝛽-gal positive cells. Obtained data
showed an increase 𝛽-gal production with age. To determine
whether the age-related decrease in cell growth results from
apoptosis level, we evaluated the percentage of dead cells
in culture (Figures 3(b) and 3(c)). The number of dead
cells increased with donor age, though without statistical
significance (𝑃 > 0.05). It reached 4.95 ± 1.4% in >20,
6.2 ± 0.8% in >50, 6.2 ± 2% in >60, and 7.7 ± 1.3% in
>70 years age group. Caspase-3 fluorescence signal intensity
was higher in the >50 and the >70 years of age group in
comparison to the >20 and >60 years groups (Figure 3(c)).
We have also observed differences between the >20 and >50
years old patients’ expression of p53 mRNAs (Figure 3(d)).
3.4. Oxidative Stress Factors Analysis in hASCs. Obtained
data showed higher ROS levels in older donors (50–70
years) in comparison to the youngest group (>20), with no
significant difference between >50, >60, and >70-year age
groups (Figure 4(a)). Similar to ROS in case of NO, pro-
gressive increasing of NO amount was positively correlated
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Figure 1: Flow cytometry and multipotency analysis. Flow cytometry dot plots representative for human adipose derived mesenchymal
stem cells (hASCs) (a). Isolated cells are characterized by the presence of CD29, CD44, CD73b, CD90, and CD105. hASCs lack the CD45
surface markers, as well as the CD34hematopoietic lineage marker. Flow cytometry analysis determined the percentage of specific markers
in total analyzed hASCs from patients in different age (b). Quantification of markers revealed no significant differences between groups.
Representative images from trilineage assay of hASCs after 21 days of differentiation (c). Osteogenically differentiated cells in monolayer
stained with Alizarin Red, chondrogenically differentiated cells using Safranin O, and adipogenically differentiated cells stained using Oil
Red O. Multipotency test was performed on ASCs isolated from patients between 25 and 77 age ranges. Magnification ×100, scale bars:
500 𝜇m. Results expressed as mean ± SD. ∗𝑃 value < 0.05.
with donor age (Figure 4(b)). We observed that SOD activity
decreased with donor age (Figure 4(c)).
3.5. Age-Related Changes in hASC Cultured under Osteogenic
Conditions. hASCs isolated from all donors were cultured
under osteogenic conditions in order to evaluate their
osteogenic differentaion potential on a functional level. A
significantly lower proliferative activity was observed in
osteoblasts precursors (Op) isolated from elderly donors
when compared to other groups. There were no significant
changes in growth kinetics of Op among elderly indyviduals
(Figure 5(a)). Population doubling time (PDT) was compa-
rable between all investigated groups, showing no significant
differences between donors of different age (Figure 5(b)).
The level of extracellularmatrix calcificationwas detected
using Alizarin Red staining and SEM-EDX technique. The
most abundant reaction for Alizarin Red as well as the high-
est concentration of calcium and phosporus was observed
in hASCs of youngest donors (Figure 5(c)). Moreover, the
largest number of formed osteonodules was observed in
the youngest donors >20 when compared to older groups
(Figure 5(d)). Furthermore we explored the relationship
between calcium and phosphorus amount in bone nodules.
The measurement revealed significant differences between
young and elderly donors, showing age-related decrease of
calcium and phosphorus deposition (Figure 5(e)) (𝑃 < 0.001
and 𝑃 < 0.05 for calcium and phosphorus, resp.). How-
ever, there were no significant changes between investigated
groups in the size of osteonodules formed (Figure 5(f)).
The highest activity of ALP in the last stage of
osteogenic culture (14th day) was observed in youngest
donors (Figure 6(a)). A similar tendency was noticed with
OPN protein levels (Figure 6(b)). Interesiengly a lower con-
centration of Col-1 protein was observed in younger patients
(Figure 6(c)). We observed that OCN amount decreases with
age as well (Figure 6(d)).
3.6. Analysis of Oxidative Stress Factors inOsteoblast Precursor
(Op). Analysis of oxidative stress level in Op was performed
at the last stage of osteogenic culture of hASC. Reactive
oxygen species (ROS) levels significantly increased with age,
8 Oxidative Medicine and Cellular Longevity
>20 years
>50 years >70 years
>60 years
1 2 5 7
Days of hASCs propagation
Growth curve
∗∗∗∗∗∗
∗∗∗
50000
100000
150000
200000
250000
C
el
l n
um
be
r
(a)
PDT
∗∗
∗∗
∗∗
>20 >50 >60 >70
Donor age (years)
(h
r)
0
50
100
150
200
(b)
CFU-E
∗∗∗
∗∗
∗∗∗
∗∗∗
∗∗∗
>20 >50 >60 >70
Donor age (years)
0
2
4
6
CF
U
-E
 (%
)
(c)
n
t
n t
t
n
nt
Gn
G
n
Gn
G
n
m
m
m
m
n
n
n
n
n
mv fp
lp
n
mv
lp
fp
n
n
lp
mv
mv
n
lp
>20
>50
>60
>70
DAPI/Phall. Mito Red Golgi-GFP Tubulin-RFP SEM
(d)
Figure 2: Effect of age on hASCs morphology, growth kinetics, and clonogenic potential. Mean cell number for each age group with respect
to culture duration (a). Significant differences in proliferation potential were observed between younger (>20) and older patients (50–70).
Cell population doubling time expressed according to donor age (b). CFU-E assay showing percentage of colonies consisting of more than 50
cells between different age groups (c). Morphology and cellular composition of hASCs from different age groups, evaluated after seven days of
propagation (d). Typical morphological features were indicated with proper abbreviations: n: nucleus, m: mitochondria, G: Golgi apparatus,
t: microtubules, mv: microvesicles, lp: lamellipodia, and fp: filopodia. Enlarged nuclei were pointed out with yellow arrows. Magnification:
DAPI/Phalloidin (DAPI/Phall.) ×100, scale bar: 250 𝜇m;Mito Red, Golgi-GFP, Tubulin RFP: ×200, and scale bars 125 𝜇m; SEM: ×2000, scale
bars: 30 𝜇m. Results expressed as mean ± SD. ∗𝑃 value < 0.05, ∗∗𝑃 value < 0.01, and ∗∗∗𝑃 value < 0.001; (>20), (>50), (>60), and (>70): donor
age range.
being the lowest in young donors. However, there were
no significant changes in ROS concentration between other
groups (Figure 7(a)). Nitric oxide levels were elevated in
youngest donors when compared to other groups. However,
there were no significant changes between donor age groups
(Figure 7(b)). Superoxide dismutase (SOD) activity was sig-
nificantly higher in young Op as compared to aged cells
(Figure 7(c)). SOD activity progressively increased in elderly
patients.
3.7. The Expression of Osteocalcin (OCL), Osteopontin (OPN),
Bone Morphogenic Protein 2 (BMP-2), Collagen Type I (Col-
1), and Alkaline Phosphatase (ALP) in Age-Related Op. The
quantative evaluation of OCL, OPN, BMP-2, and ALP
mRNA level reveled significant differences between tran-
scripts expresion between Op derived from youg donors and
elderly indyviduals (Figures 8(a)–8(e)). We observed higher
expression of OCL, OPN, and BMP-2mRNA level in younger
donors. Interestinlgy, the elevated expresion of ALP mRNA
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level was noticed in the ederly group when compared with
younger donors.
3.8. Age-Related Changes in hASC Cultured under Adipogenic
Condition. To confirm functionality of hASC adipogenic
differentiation, adipocytes precursors (Ap) were stained with
Oil RedOdye on the 14th day (Figure 9(a)). Formation of first
lipid droplets was observed on the 7th day of culture, with the
greatest amount of fat droplets in the >20 years group. On the
14th day of culture adipocytes presented comparable amounts
of lipid droplets.
Growth kinetics of Ap was evaluated during 14-day
culture (Figure 9(b)).The performed test revealed that the Ap
derived from elderly donors proliferated significantly faster
than Ap of young donors. However, after the 14th day of
culture, Ap reached comparable number in all investigated
groups.The highest PDTwas observed in the>20 years group
(118 ± 16.55 h) (Figure 9(c)).
Expression of PPAR𝛾 (Figure 9(d)) was significantly
higher in age groups between 50 and 70 years old in com-
parison to young donors (>20). Significantly lower protein
concentration of both adiponectin and leptin was observed
in younger donors (Figures 9(e) and 9(f)).
Number of lipid droplets (Figure 9(g)) and Oil Red O
stained area (Figure 9(h)), was progressively increasing with
donor age, showing significant differences between investi-
gated groups.
3.9. Analysis of the Oxidative Stress Factors in Ap. ROS activ-
ity in Ap culture was significantly lower (𝑃 < 0.05) in young
donors when compared to other age groups (Figure 10(a)).
NO concentration differences were not significant between
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Figure 4: Analysis of oxidative stress factors in hASCs. Reactive oxygen species (a), nitric oxide (b), and superoxide dismutase (c). Results
expressed as mean ± SD. ∗𝑃 value < 0.05.
the analyzed groups (Figure 10(b)). Superoxide activity sig-
nificantly decreased with donor age; it was 2.6-fold lower
in the >70 years group when compared with the >20 years
group.
4. Discussion
Nowadays, rapid ageing of populations becomes a real chal-
lenge for national healthcare systems, global economy, and
medicine [25]. As the World Health Organization (WHO)
predicts, the next few decades will bring a change to the
prevalence of diseases making age-related illnesses (e.g.,
cardiovascular disease, Alzheimer’s disease, osteoporosis,
arthritis, and diabetes) more common than infectious dis-
eases, childhood diseases, or accidents [26]. Regenerative
medicine, including stem cell therapy, may be a potential
solution to this problem. Thus, the evaluation of correlation
between osteogenic and adipogenic differentiation potential
of MSCs, their proliferative activity, viability, and senescence
level in the context of their potential clinical applications
seems to be justified. Moreover, correlative analysis of
oxidative stress factors including ROS, NO, and superoxide
dismutase, which is an antioxidant scavenger that protects
tissues within the body from oxidative damage [27], might
deliver valuable knowledge concerning suitability of MSCs
isolated from elderly patients in clinical practice. What is
more, obtained data might suggest the necessity to find an
alternative approach to elderly donors, which are qualified to
stem cell therapy, and might convince clinicians to enhance
proliferative and differentiating potential of isolated MSCs,
before clinical application.
Isolated hASCs from both younger and older donors
exhibited typical for MSCs shape, morphology,and pheno-
type.ObtainedhASCs expressed all ofmesenchymalmarkers,
for example, CD44, CD73, CD90, and CD105 and lacked
hematopoieticmarkers: CD34 andCD45.We observed quan-
titative changes between expressions of CD73 surface marker
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Figure 5: Age-related changes in hASC cultured under osteogenic conditions. Growth curves (a), population doubling time (b).
Morphological evaluation after 16 days of culture, magnification ×100, scale bars: 250𝜇m; SEM pictures; magnification ×2000, scale bars:
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and on: osteo-nodule.
in relation to donor age, which may contribute to decreased
proliferation potential of aged hASCs.
In this study we presented that proliferative activity (PA),
clonogenic potential, and PDT were significantly different
between hASCs isolated from young patients (>20 years of
age) when compared to older donors (50–70 years of age).
Interestingly, there were no significant changes in regard to
PA and PDT between patients differing in age, what suggests
that the proliferative potential of hASCs within the tissue is
not correlated with increasing age. Obtained data stand in
good agreement with the findings of Zhu et al. [28], who
also noticed substantial differences in both PA and PDT, in
young patients compared to older donors. Schipper et al. [29]
have also observed that hASCs isolated fromyounger patients
proliferate faster when compared with older donors. We have
also observed reduced potential of CFU forming in older
patients. Decreased proliferation capacity as well as number
of CFU, which correlate with hASCs expansion in vitro, may
be especially questionable when considering usage of those
cells in therapies.
The proliferative potential, senescence, and apoptosis
level in hASCs isolated from older patients might be directly
linked to oxidative stress. In this study we observed a
significant tendency to form apoptotic bodies (caspase-
3 positive cells) as well increasing number of senescent
cells accumulating 𝛽-galactosidase in regard to patient age,
with simultaneously elevated levels of ROS and NO. At the
same time we noticed decreased antioxidative protection
originating from SOD activity in the group of older donors.
This correlates with our observations regarding decreasing
mitochondrial activity aswell asGolgi bodies in older donors.
Obtained data stand in good agreement with Stolzing et al.
[30] findings that showed correlation between oxidative stress
and apoptosis, as well as senescence level in MSCs culture. It
is worth underlining that there were no statistical differences
between ROS and NO level in the group of older donors
what might indicate that oxidative processes in regard to
elderly age are maintained on a comparable level. We also
observed, in accordance with Zhou et al. [31], age-related
changes in mRNA level of the p53 protein, which is well
known for its role in apoptosis induction. Obtained results
suggest that upregulation of p53 may be responsible for age-
related decreases in proliferation potential, as well as for
apoptotic susceptibility of hASCs. We have also observed
enlarged nuclei, which is associated with cell senescence [32].
In recent years, many studies indicate the multilineage
differentiation potential of hASCs [33]. However, we were
interested whether ASCs isolated from older donors might
be useful in regenerative medicine and tissue engineering.
In the current study, we observed an increase in calcium
accumulation, osteo-nodules formation, and elevated expres-
sion of BMP-2, OPN, and OCL on mRNA and protein
levels in younger donors when compared to the elderly. The
observed lower but comparable level of above mentioned
gene expression in older donorsmight suggest to some extent
that MSCs show differentiation stability in those patients.
Surprisingly there were no statistical differences between
expression of COL-1 on the mRNA level between younger
and older patients, what might indicate that age dos not
effect COL-1 expression on the mRNA level. In addition, we
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Figure 6: Protein levels in hASCs osteogenic culture. Alkaline phosphatase activity, evaluated on 7th and 14th day of culture in osteogenic
conditions (a). Quantitative ELISA analysis of extracellular osteopontin (b), collagen I (c), and osteoclacin (d). Results expressed as mean ±
SD. ∗𝑃 value < 0.05, ∗∗𝑃 value < 0.01.
have found a decrease of ROS with simultaneous elevated
level of SOD in younger donors when compared to older
donors. As reported by Chen and colleagues [34] this might
be due to a change in energy production from glycolysis to
oxidative phosphorylation in MSCs upon osteogenic induc-
tion. In turn, in older donors we observed a linear inverse
relation between ROS accumulation and SOD activity. It
might suggest that MSCs lose their antioxidative protection
with age. Interestingly, we have found that the highest level
of NO was detected in the youngest donors in relation to
other groups. The obtained data stand in good agreement
with Xiao et al. [35] who found that releasing of NO by
MSCs, cultured in osteogenic conditioned media, promotes
their ability to differentiate into osteoblasts. In turn, Geula
et al. [36] have reported that NO also promotes MSCs
differentiation into adipocytes. In our studywe have observed
an elevated level of NO in the oldest group of donors, with
simultaneous inhibition of NO secretion in the youngest
one. In addition we observed that PF of differentiated MSCs
was significantly higher in older donors when compared to
young patients. Also, the cultured adipogenic precursorswere
characterized by significantly shorter PDT in comparison to
younger donors. Moreover, we have found that both leptin
and adiponectin concentrationswere elevated in older donors
when compared with younger patients. The simultaneous
increase in the level of adiponectin and leptin in differentiated
MSCs derived from older patients might be to some extent
considered as a factor negatively effecting bone regeneration.
Adiponectin and its receptor are expressed in osteoblasts;
thus this substance may play an important role in bone
14 Oxidative Medicine and Cellular Longevity
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Figure 7: Analysis of oxidative stress factors in osteoblast precursors (Op). Reactive oxygen species (a), nitric oxide (b), and superoxide
dismutase (c). Results expressed as mean ± SD. ∗𝑃 value < 0.05, ∗∗𝑃 value < 0.01.
metabolism. As studies show, serum adiponectin level is
negatively correlated with bone mineral density [37]. Some
authors also postulate the theory of the so-called “adipogenic
switch.” It states that in advanced age MSCs lose their
osteogenic potential and in turn gain an adipogenic potential
[38], which leads to senile osteoporosis [39]. This correlates
well with our results, as we have observed decreased BMP-
2 gene expression in older patients, which might support
the mentioned theory, as this cytokine is essential in
osteoblasts maturation. We have also noticed increased
expression of PPAR𝛾 in elderly patients. This protein is
known as a central transcriptional regulator of adipogenic
pathway. Expression of PPAR𝛾 in ASCs increases with age;
thus it may be a major factor controlling cells fate by
activating adipogenesis at the expense of osteogenesis [40].
Thus it is possible that increased number of adipocytes and
decreased number of osteoblast in differentiated ASCs may
be due to upregulated PPAR𝛾 activity. This imbalance in
differentiation capacity results in reduced bone formation
and increased risk for osteoporosis [30]. Moreover, we found
an increased level of ROS in adipogenic differentiated MSCs
with simultaneous lipid accumulations in the group of older
donors, which may suggest that ROS accumulation does not
decrease adipogenic potential.
Aging is a complex process, at which molecular basis still
remains to be elucidated. Epigenetic changes like histones
modification and DNA methylation are thought to play a
significant role in this process [41]. It is known that in
many aged cell types the global DNA methylation status
is significantly increased [42]. Recent studies showed that
5-Azacytidine, which inhibits the activity of DNA methyl-
transferases (DNMTs) promotes DNA demethylation in aged
hASCs. Moreover it increased cell proliferation and acceler-
ated osteogenic differentiation, causing rejuvenation of aged
cells [43]. Another approach to hASC rejuvenation may be
treating themwith antioxidants to reduce ROS levels. A study
conducted by Lin et al. [44] revealed that culturing hASCs in
a growth medium with a low concentration of calcium and
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Figure 8: Reverse transcriptase-polymerase chain reaction (RT-PCR) results. Gene expression in hASC cultured in osteogenesis-promoting
conditions. Osteopontin (a), collagen type I (b), osteocalcin (c), bonemorphogenetic protein 2 (d), and alkaline phosphatase (e)mRNA levels.
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Figure 9: Continued.
Oxidative Medicine and Cellular Longevity 17
∗
Leptin
>20 >50 >60 >70
Donor age (years)
0
2
4
6
8
10
Le
pi
n 
(n
g/
m
L)
(f)
∗∗∗
∗∗
∗∗
∗
∗
Lipid droplets
>20 >50 >60 >70
Donor age (years)
0
100
200
300
350
(g)
∗
∗∗
Oil Red O positive area
>20 >50 >60 >70
Donor age (years)
0
10
20
30
40
50
(%
)
(h)
Figure 9: Adipogenic differentation analysis. Morphological evaluation on 7th, 11th, and 14th day. Oil Red O and DAPI/Phalloidin staining
performed on 14th day (a);magnification×100, scale bars: 77𝜇m;Oil RedO andDAPI/Phallo.Magnification×100, scale bars: 250𝜇m.Growth
curve (b) showing significantly slower proliferation rate in young patients (>20). No statistically important differences in population doubling
time were seen between the different age groups (c). Expression level of PPAR𝛾 (d) and concentration of leptin (e) and adiponectin (f) in the
supernatants on the 14th day, measured with ELISA assay. Obtained data display differences in leptin amount between >20 and >60 patients,
respectively, as well as age-related increase in adiponectin expression in hASC obtained from older subjects (50–70 years). Quantification od
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supplemented with N-acetyl-L-cysteine, as well as L-ascorbic
acid-2-phosphate not only accelerated stem cells growth but
also prolonged their lifespan.
5. Conclusions
The current study revealed that growth kinetics of hASCs
is positively correlated with donor age. The number of
both apoptotic and senescent cells increases with age. While
hASCss osteogenic differentiation potential decreased with
donor age, the adipogenic differentiation potential seemed
to remain on the same level throughout the whole ageing
process. Demonstrated results show the need for efficient
biotechnological solutions that might rejuvenate MSCs in
vitro, especially when clinical applications are considered.
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